We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$89.7B
AUM Growth
-$6.37B
Cap. Flow
-$1.25B
Cap. Flow %
-1.39%
Top 10 Hldgs %
19.07%
Holding
4,574
New
72
Increased
2,420
Reduced
1,279
Closed
355

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 16.22%
3 Financials 13.45%
4 Consumer Discretionary 9.63%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLRS
3051
Kalaris Therapeutics
KLRS
$96.8M
$239K ﹤0.01%
1,322
+225
+21% +$35.1K
VFVA icon
3052
Vanguard US Value Factor ETF
VFVA
$914M
$238K ﹤0.01%
2,744
+716
+35% +$69.2K
RMNI icon
3053
Rimini Street
RMNI
$471M
$235K ﹤0.01%
50,378
+17,511
+53% +$98.3K
USLM icon
3054
United States Lime & Minerals
USLM
$3.44B
$235K ﹤0.01%
11,445
+595
+5% +$12.7K
QUOT
3055
DELISTED
Quotient Technology Inc
QUOT
$234K ﹤0.01%
101,163
-11,356
-10% -$27.8K
BATRA icon
3056
Atlanta Braves Holdings Series A
BATRA
$3.43B
$233K ﹤0.01%
8,269
+44
+0.5% +$1.25K
BOOM icon
3057
DMC Global
BOOM
$157M
$233K ﹤0.01%
14,568
+112
+0.8% +$2.27K
IVR icon
3058
Invesco Mortgage Capital
IVR
$805M
$233K ﹤0.01%
20,960
+144
+0.7% +$2.24K
ASLE icon
3059
AerSale
ASLE
$279M
$232K ﹤0.01%
12,445
+67
+0.5% +$1.24K
ATRA icon
3060
Atara Biotherapeutics
ATRA
$76.1M
$232K ﹤0.01%
2,461
+44
+2% +$4.94K
MASS icon
3061
908 Devices
MASS
$364M
$232K ﹤0.01%
14,118
+2,072
+17% +$40.2K
DYN icon
3062
Dyne Therapeutics
DYN
$4.9B
$231K ﹤0.01%
18,162
+147
+0.8% +$1.69K
ERTH icon
3063
Invesco MSCI Sustainable Future ETF
ERTH
$138M
$231K ﹤0.01%
4,742
+1,560
+49% +$86.9K
HCI icon
3064
HCI Group
HCI
$2.41B
$230K ﹤0.01%
5,859
+3
+0.1% +$172
OLP
3065
One Liberty Properties
OLP
$527M
$230K ﹤0.01%
10,941
+75
+0.7% +$1.9K
TDCX
3066
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$230K ﹤0.01%
24,614
+7,450
+43% +$64.9K
DOUG icon
3067
Douglas Elliman
DOUG
$162M
$229K ﹤0.01%
58,545
-5,030
-8% -$24.8K
FYX icon
3068
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.4B
$229K ﹤0.01%
3,149
+1,799
+133% +$146K
EGRX
3069
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$229K ﹤0.01%
8,661
+154
+2% +$5.65K
GWH icon
3070
ESS Tech
GWH
$18.9M
$228K ﹤0.01%
3,719
-677
-15% -$40.1K
HUT
3071
Hut 8
HUT
$10.9B
$228K ﹤0.01%
25,734
+20
+0.1% +$208
QBTS icon
3072
D-Wave Quantum Inc. Common Stock
QBTS
$7.69B
$228K ﹤0.01%
+29,000
New +$232K
EBIZ icon
3073
Global X E-commerce ETF
EBIZ
$29.5M
$227K ﹤0.01%
14,952
+5,671
+61% +$99.6K
FLWS icon
3074
1-800-Flowers.com
FLWS
$258M
$226K ﹤0.01%
34,888
+155
+0.4% +$1.37K
GILT icon
3075
Gilat Satellite Networks
GILT
$848M
$226K ﹤0.01%
42,425
+18,626
+78% +$119K

Similar funds

Credit Suisse's Q3 2022 Portfolio in Review

As of Q3 2022, Credit Suisse held 4,574 positions worth $89.7B, down 6.6% from $96.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Credit Suisse's Q3 2022 filing shows 72 new, 2,420 increased, 1,279 reduced and 355 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $205M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2022 buy was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M.
  • Credit Suisse added most to Apple in Q3 2022, an estimated $180M increase.
  • Credit Suisse's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $205M.
  • Credit Suisse fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $40.9M.
  • Credit Suisse's ten largest holdings make up 19% of its $89.7B portfolio in Q3 2022.
  • Credit Suisse opened 72 new positions and closed 355 in Q3 2022.
  • Credit Suisse's portfolio value fell 6.6% quarter-over-quarter to $89.7B.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.